[1] |
ELTZSCHIG HK, ECKLE T. Ischemia and reperfusion--from mechanism to translation[J]. Nat Med, 2011, 17(11): 1391-1401. DOI: 10.1038/nm.2507.
|
[2] |
PRZYKAZA Ł. Understanding the connection between common stroke comorbidities, their associated inflammation, and the course of the cerebral ischemia/reperfusion cascade[J]. Front Immunol, 2021, 12: 782569. DOI: 10.3389/fimmu.2021.782569.
|
[3] |
HAUSENLOY DJ, YELLON DM. Myocardial ischemia-reperfusion injury: a neglected therapeutic target[J]. J Clin Invest, 2013, 123(1): 92-100. DOI: 10.1172/JCI62874.
|
[4] |
JIMÉNEZ-CASTRO MB, CORNIDE-PETRONIO ME, GRACIA-SANCHO J, et al. Inflammasome-mediated inflammation in liver ischemia-reperfusion injury[J]. Cells, 2019, 8(10): 1131. DOI: 10.3390/cells8101131.
|
[5] |
MANTOVANI A, SICA A, LOCATI M. Macrophage polarization comes of age[J]. Immunity, 2005, 23(4): 344-346. DOI: 10.1016/j.immuni.2005.10.001.
|
[6] |
LAZAROV T, JUAREZ-CARREÑO S, COX N, et al. Physiology and diseases of tissue-resident macrophages[J]. Nature, 2023, 618(7966): 698-707. DOI: 10.1038/s41586-023-06002-x.
|
[7] |
GESKE FJ, MONKS J, LEHMAN L, et al. The role of the macrophage in apoptosis: hunter, gatherer, and regulator[J]. Int J Hematol, 2002, 76(1): 16-26. DOI: 10.1007/BF02982714.
|
[8] |
VAROL C, MILDNER A, JUNG S. Macrophages: development and tissue specialization[J]. Annu Rev Immunol, 2015, 33: 643-675. DOI: 10.1146/annurev-immunol-032414-112220.
|
[9] |
MOSSER DM, EDWARDS JP. Exploring the full spectrum of macrophage activation[J]. Nat Rev Immunol, 2008, 8(12): 958-969. DOI: 10.1038/nri2448.
|
[10] |
陈玮钰, 覃小宾, 乐滢玉, 等. 巨噬细胞极化在非肿瘤性肝脏疾病中的作用机制及其靶向治疗[J]. 临床肝胆病杂志, 2022, 38(11): 2649-2653. DOI: 10.3969/j.issn.1001-5256.2022.11.042.CHEN WY, QIN XB, LE YY, et al. Mechanism of action of macrophage polarization in non-neoplastic liver diseases and related targeted therapies[J]. J Clin Hepatol, 2022, 38(11): 2649-2653. DOI: 10.3969/j.issn.1001-5256.2022.11.042.
|
[11] |
WANG H, XI Z, DENG L, et al. Macrophage polarization and liver ischemia-reperfusion injury[J]. Int J Med Sci, 2021, 18(5): 1104-1113. DOI: 10.7150/ijms.52691.
|
[12] |
SHAPOURI-MOGHADDAM A, MOHAMMADIAN S, VAZINI H, et al. Macrophage plasticity, polarization, and function in health and disease[J]. J Cell Physiol, 2018, 233(9): 6425-6440. DOI: 10.1002/jcp.26429.
|
[13] |
ZHANG H, LI Z, LI W. M2 macrophages serve as critical executor of innate immunity in chronic allograft rejection[J]. Front Immunol, 2021, 12: 648539. DOI: 10.3389/fimmu.2021.648539.
|
[14] |
王静,高煜茹,蔡钱伟, 等. 瑞马唑仑通过调节肺泡巨噬细胞极化减轻脂多糖诱导的急性肺损伤[J]. 实用医学杂志, 2023, 39(9): 1092-1097. DOI: 10.3969/j.issn.1006-5725.2023.09.005.WANG J, GAO YR, CAI QW, et al. Remimazolam alleviates LPS-induced acute lung injury by regulating macrophage polarization[J]. J Pract Med, 2023, 39(9): 1092-1097. DOI: 10.3969/j.issn.1006-5725.2023.09.005.
|
[15] |
PENG Q, NOWOCIN A, RATNASOTHY K, et al. Inhibition of thrombin on endothelium enhances recruitment of regulatory T cells during IRI and when combined with adoptive Treg transfer, significantly protects against acute tissue injury and prolongs allograft survival[J]. Front Immunol, 2023, 13: 980462. DOI: 10.3389/fimmu.2022.980462.
|
[16] |
HU Z, ZHAN J, PEI G, et al. Depletion of macrophages with clodronate liposomes partially attenuates renal fibrosis on AKI-CKD transition[J]. Ren Fail, 2023, 45(1): 2149412. DOI: 10.1080/0886022X.2022.2149412.
|
[17] |
LAN T, BI F, XU Y, et al. PPAR-γ activation promotes xenogenic bioroot regeneration by attenuating the xenograft induced-oxidative stress[J]. Int J Oral Sci, 2023, 15(1): 10. DOI: 10.1038/s41368-023-00217-4.
|
[18] |
WANG S, CAI Y, BU R, et al. PPARγ regulates macrophage polarization by inhibiting the JAK/STAT pathway and attenuates myocardial ischemia/reperfusion injury in vivo[J]. Cell Biochem Biophys, 2023, 81(2): 349-358. DOI: 10.1007/s12013-023-01137-0.
|
[19] |
POPOV SV, MUKHOMEDZYANOV AV, VORONKOV NS, et al. Regulation of autophagy of the heart in ischemia and reperfusion[J]. Apoptosis, 2023, 28(1/2): 55-80. DOI: 10.1007/s10495-022-01786-1.
|
[20] |
SHAO X, XU P, JI L, et al. Low-dose decitabine promotes M2 macrophage polarization in patients with primary immune thrombocytopenia via enhancing KLF4 binding to PPARγ promoter[J]. Clin Transl Med, 2023, 13(7): e1344. DOI: 10.1002/ctm2.1344.
|
[21] |
SUN K, LI YY, JIN J. A double-edged sword of immuno-microenvironment in cardiac homeostasis and injury repair[J]. Signal Transduct Target Ther, 2021, 6(1): 79. DOI: 10.1038/s41392-020-00455-6.
|
[22] |
WU X, SINGLA S, LIU JJ, et al. The role of macrophage ion channels in the progression of atherosclerosis[J]. Front Immunol, 2023, 14: 1225178. DOI: 10.3389/fimmu.2023.1225178.
|
[23] |
PENG Y, ZHOU M, YANG H, et al. Regulatory mechanism of M1/M2 macrophage polarization in the development of autoimmune diseases[J]. Mediators Inflamm, 2023: 8821610. DOI: 10.1155/2023/8821610.
|
[24] |
董星辰, 孙晓阳. 趋化因子及其受体在胶质瘤诊断及治疗中的研究进展[J]. 医学综述, 2022, 28(12): 2403-2407. DOI: 10.3969/j.issn.1006-2084.2022.12.020.DONG XC, SUN XY. Research progress of chemokines and their receptors in diagnosis and treatment of glioma[J]. Med Recap, 2022, 28(12): 2403-2407. DOI: 10.3969/j.issn.1006-2084.2022.12.020.
|
[25] |
ZHUANG L, ZONG X, YANG Q, et al. Interleukin-34-NF-κB signaling aggravates myocardial ischemic/reperfusion injury by facilitating macrophage recruitment and polarization[J]. EBioMedicine, 2023, 95: 104744. DOI: 10.1016/j.ebiom.2023.104744.
|
[26] |
WANG J, LIU X, GU Y, et al. DNA binding protein YB-1 is a part of the neutrophil extracellular trap mediation of kidney damage and cross-organ effects[J]. Kidney Int, 2023, 104(1): 124-138. DOI: 10.1016/j.kint.2023.02.032.
|
[27] |
TANG W, PANJA S, JOGDEO CM, et al. Modified chitosan for effective renal delivery of siRNA to treat acute kidney injury[J]. Biomaterials, 2022, 285: 121562. DOI: 10.1016/j.biomaterials.2022.121562.
|
[28] |
WEI X, WEN Y, HU Y, et al. Total saponins of Panax notoginseng modulate the astrocyte inflammatory signaling pathway and attenuate inflammatory injury induced by oxygen-glucose deprivation/reperfusion injury in rat brain microvascular endothelial cells[J]. Curr Stem Cell Res Ther, 2024, 19(2): 267-276. DOI: 10.2174/1574888X18666230509113912.
|
[29] |
YOO KD, CHA RH, LEE S, et al. Chemokine receptor 5 blockade modulates macrophage trafficking in renal ischaemic-reperfusion injury[J]. J Cell Mol Med, 2020, 24(10): 5515-5527. DOI: 10.1111/jcmm.15207.
|
[30] |
CANTERO-NAVARRO E, RAYEGO-MATEOS S, OREJUDO M, et al. Role of macrophages and related cytokines in kidney disease[J]. Front Med (Lausanne), 2021, 8: 688060. DOI: 10.3389/fmed.2021.688060.
|
[31] |
ZHANG H, LIU Y, CAO X, et al. Nrf2 promotes inflammation in early myocardial ischemia-reperfusion via recruitment and activation of macrophages[J]. Front Immunol, 2021, 12: 763760. DOI: 10.3389/fimmu.2021.763760.
|
[32] |
LI J. Alterations in cell adhesion proteins and cardiomyopathy[J]. World J Cardiol, 2014, 6(5): 304-313. DOI: 10.4330/wjc.v6.i5.304.
|
[33] |
MARCHINI T, MITRE LS, WOLF D. Inflammatory cell recruitment in cardiovascular disease[J]. Front Cell Dev Biol, 2021, 9: 635527. DOI: 10.3389/fcell.2021.635527.
|
[34] |
ROUSHANSARAI NS, PASCHER A, BECKER F. Innate immune cells during machine perfusion of liver grafts-the janus face of hepatic macrophages[J]. J Clin Med, 2022, 11(22): 6669. DOI: 10.3390/jcm11226669.
|
[35] |
LU TF, YANG TH, ZHONG CP, et al. Dual effect of hepatic macrophages on liver ischemia and reperfusion injury during liver transplantation[J]. Immune Netw, 2018, 18(3): e24. DOI: 10.4110/in.2018.18.e24.
|
[36] |
WANG M, PAN W, XU Y, et al. Microglia-mediated neuroinflammation: a potential target for the treatment of cardiovascular diseases[J]. J Inflamm Res, 2022, 15: 3083-3094. DOI: 10.2147/JIR.S350109.
|
[37] |
SUN XR, YAO ZM, CHEN L, et al. Metabolic reprogramming regulates microglial polarization and its role in cerebral ischemia reperfusion[J]. Fundam Clin Pharmacol, 2023, 37(6): 1065-1078. DOI: 10.1111/fcp.12928.
|
[38] |
LIU H, LI Y, XIONG J. The role of hypoxia-inducible factor-1 alpha in renal disease[J]. Molecules, 2022, 27(21): 7318. DOI: 10.3390/molecules27217318.
|
[39] |
ZHENG J, CHEN P, ZHONG J, et al. HIF-1α in myocardial ischemia-reperfusion injury (review)[J]. Mol Med Rep, 2021, 23(5): 352. DOI: 10.3892/mmr.2021.11991.
|
[40] |
LIANG Y, QU L, LIU Z, et al. The IRE1/JNK signaling pathway regulates inflammation cytokines and production of glomerular extracellular matrix in the acute kidney injury to chronic kidney disease transition[J]. Mol Biol Rep, 2022, 49(8): 7709-7718. DOI: 10.1007/s11033-022-07588-7.
|
[41] |
FLORES-VERGARA R, OLMEDO I, ARÁNGUIZ P, et al. Communication between cardiomyocytes and fibroblasts during cardiac ischemia/reperfusion and remodeling: roles of TGF-β, CTGF, the renin angiotensin axis, and non-coding RNA molecules[J]. Front Physiol, 2021, 12: 716721. DOI: 10.3389/fphys.2021.716721.
|
[42] |
ELWANY NE, ABDELHAMID AM, MOHAMED NM, et al. Vinpocetine alleviates intestinal ischemia/reperfusion injury and enhances M2 macrophage polarization in rats: role of SIRT1/SOCS3/STAT3 signaling pathway[J]. Int Immunopharmacol, 2023, 122: 110654. DOI: 10.1016/j.intimp.2023.110654.
|
[43] |
XU Z, WANG X, KUANG W, et al. Kaempferol improves acute kidney injury via inhibition of macrophage infiltration in septic mice[J]. Biosci Rep, 2023, 43(7): BSR20230873. DOI: 10.1042/BSR20230873.
|
[44] |
ZHANG J, LIU L, DONG Z, et al. An ischemic area-targeting, peroxynitrite-responsive, biomimetic carbon monoxide nanogenerator for preventing myocardial ischemia-reperfusion injury[J]. Bioact Mater, 2023, 28: 480-494. DOI: 10.1016/j.bioactmat.2023.05.017.
|
[45] |
CHANG FC, LIU CH, LUO AJ, et al. Angiopoietin-2 inhibition attenuates kidney fibrosis by hindering chemokine C-C motif ligand 2 expression and apoptosis of endothelial cells[J]. Kidney Int, 2022, 102(4): 780-797. DOI: 10.1016/j.kint.2022.06.026.
|
[46] |
CHEN S, LI A, WU J, et al. Dexmedetomidine reduces myocardial ischemia-reperfusion injury in young mice through MIF/AMPK/GLUT4 axis[J]. BMC Anesthesiol, 2022, 22(1): 289. DOI: 10.1186/s12871-022-01825-z.
|
[47] |
LUQUE-CAMPOS N, BUSTAMANTE-BARRIENTOS FA, PRADENAS C, et al. The macrophage response is driven by mesenchymal stem cell-mediated metabolic reprogramming[J]. Front Immunol, 2021, 12: 624746. DOI: 10.3389/fimmu.2021.624746.
|
[48] |
ZHAO J, LI X, HU J, et al. Mesenchymal stromal cell-derived exosomes attenuate myocardial ischaemia-reperfusion injury through miR-182-regulated macrophage polarization[J]. Cardiovasc Res, 2019, 115(7): 1205-1216. DOI: 10.1093/cvr/cvz040.
|